Cargando…
Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
OBJECTIVE: The aim of this manuscript was to report the risk of incident peripheral arterial disease (PAD) in a large randomized clinical trial that enrolled participants with stable coronary artery disease and type 2 diabetes and compare the risk between assigned treatment arms. RESEARCH DESIGN AND...
Autores principales: | Althouse, Andrew D., Abbott, J. Dawn, Sutton-Tyrrell, Kim, Forker, Alan D., Lombardero, Manuel S., Buitrón, L. Virginia, Pena-Sing, Ivan, Tardif, Jean-Claude, Brooks, Maria Mori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781574/ https://www.ncbi.nlm.nih.gov/pubmed/23735723 http://dx.doi.org/10.2337/dc12-2265 |
Ejemplares similares
-
The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
por: Singh, Premranjan P., et al.
Publicado: (2011) -
Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes: Results From the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial
por: Althouse, Andrew D., et al.
Publicado: (2014) -
Impact of Glycemic Control Strategies on the Progression of Diabetic Peripheral Neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort
por: Pop-Busui, Rodica, et al.
Publicado: (2013) -
Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
por: Schneider, David J., et al.
Publicado: (2009) -
An Aggregate Biomarker Risk Score Predicts High Risk of Near‐Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
por: Ghasemzadeh, Nima, et al.
Publicado: (2017)